Publikationen pro Jahr
Publikationen pro Jahr
Publikationen
- 8 Ergebnisse
Suchergebnisse
-
2023
Bone marrow microenvironment- induced regulation of Bcl-2 family members in multiple myeloma (MM): Therapeutic implications
Aksoy, O., Lind, J., Sunder-Plaßmann, V., Vallet, S. & Podar, K., Jan. 2023, in: Cytokine. 161, S. 156062 156062.Publikation: Beitrag in Fachzeitschrift (peer-reviewed) › Artikel in Fachzeitschrift
Open Access2 Zitate (Scopus) -
2022
1255 Impact of immune checkpoint inhibitors on bone turnover in cancer patients: prospective clinical study and preclinical correlates
Gassner, T., Vallet, S., Chittilappilly, C., Pirich, T., Lind, J., Aksoy, O., Sunder-Plassmann, V., Hackner, K., Zwickl-Traxler, E., Errhalt, P., Pecherstorfer, M. & Podar, K., 2022, in: Journal for ImmunoTherapy of Cancer. S. A1300-A1300Publikation: Beitrag in Fachzeitschrift (peer-reviewed) › Konferenzbeitrag in Fachzeitschrift
Open Access -
Die Auswirkung von Osteoblasten und deren Präkursoren auf das Schicksal von Brustkrebszellen
Lind, J., Gassner, T., Aksoy, O., Sunder-Plaßmann, V., Pecherstorfer, M., Podar, K. & Vallet, S., 27 Sept. 2022, in: Oncology Research and Treatment. 45 | Meeting Reports/Abstracts, Suppl. 2, P360.Publikation: Beitrag in Fachzeitschrift (peer-reviewed) › Konferenzbeitrag in Fachzeitschrift
Open Access2 Zitate (Scopus) -
On the continuous (R)evolution of antibody-based and CAR T cell therapies in multiple myeloma: an early 2022 glance into the future
Sunder-Plassmann, V., Aksoy, O., Lind, J., Pecherstorfer, M., Vallet, S. & Podar, K., 2022, in: Expert Opinion on Pharmacotherapy. 23, 12, S. 1425-1444 20 S.Publikation: Beitrag in Fachzeitschrift (peer-reviewed) › Übersichtsartikel
1 Zitat (Scopus) -
2021
Combined Targeting of Distinct c-Myc and JunB Transcriptional Programs Inducing Synergistic Anti-Myeloma Activity
Lind, J., Vallet, S., Kollmann, K., Aksoy, O., Sunder-Plassmann, V., Fan, F., Zwickl-Traxler, E., Stoiber, D., Bakiri, L., Wagner, E. F., Sattler, M., Pecherstorfer, M. & Podar, K., 2021, in: Blood. 138, Supplement 1, 2644.Publikation: Beitrag in Fachzeitschrift (peer-reviewed) › Artikel in Fachzeitschrift
-
Delineating CDK9 Regulated Molecular Events for the Development of Rationally Derived Multiple Myeloma Treatment Strategies
Aksoy, O., Lind, J., Sunder-Plassmann, V., Pecherstorfer, M., Vallet, S. & Podar, K., 2021, in: Blood. 138, Supplement 1, 1598.Publikation: Beitrag in Fachzeitschrift (peer-reviewed) › Artikel in Fachzeitschrift
-
OAB-030: Combined targeting of distinct c-Myc and JunB transcriptional programs induces synergistic anti-myeloma activity: 18th International Myeloma Workshop, 08.-11.09.2021, Vienna, Austria
Lind, J., Vallet, S., Kollmann, K., Aksoy, O., Sunder-Plassmann, V., Zwickl-Traxler, E., Fan, F., Stoiber-Sakaguchi, D., Bakiri, L., Wagner, E., Sattler, M., Pecherstorfer, M. & Podar, K., 2021, in: Clinical Lymphoma, Myeloma and Leukemia. 21, S. S19-S20Publikation: Beitrag in Fachzeitschrift (peer-reviewed) › Konferenzbeitrag in Fachzeitschrift
-
P-082: Delineating CDK9- regulated molecular events for the development of rationally derived multiple myeloma treatment strategies: 18th International Myeloma Workshop, 08.-11.09.2021, Vienna, Austria
Aksoy, O., Lind, J., Sunder-Plassmann, V., Pecherstorfer, M., Vallet, S. & Podar, K., 2021, in: Clinical Lymphoma, Myeloma and Leukemia. 21, S. S83-S84Publikation: Beitrag in Fachzeitschrift (peer-reviewed) › Konferenzbeitrag in Fachzeitschrift